3/4
10:17 am
clrb
Cellectar (CLRB) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Cellectar (CLRB) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/4
07:51 am
clrb
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates [Yahoo! Finance]
Medium
Report
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates [Yahoo! Finance]
3/4
07:15 am
clrb
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
Medium
Report
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
2/25
08:05 am
clrb
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
Low
Report
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
2/17
08:05 am
clrb
Cellectar Biosciences Expands Global Intellectual Property Estate
High
Report
Cellectar Biosciences Expands Global Intellectual Property Estate
1/9
08:05 am
clrb
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
Medium
Report
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
12/16
08:37 am
clrb
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies [Yahoo! Finance]
Low
Report
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies [Yahoo! Finance]
12/16
08:05 am
clrb
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
Medium
Report
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies